Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Oct 2025 for CORCEPT THERAPEUTICS INC, €27k. Read the official filing
Filing timeline
BuySaleDaniel N. Swisher Jr.
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-3.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Daniel N. Swisher Jr.: trading record in brief
This profile gathers the share dealings of Daniel N. Swisher Jr. across 3 companies, led by Corcept Therapeutics Inc, Cerus Corp and Jazz Pharmaceuticals plc. In total, 42 filings cover trades dated from 18 May 2021 to 10 October 2025.
No open-market sale appears; the market trades are 2 purchases worth €13k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 7 share grants and 32 option exercises.
Most recently, on 15 October 2025, the filings show an option exercise worth €27k in Corcept Therapeutics Inc. The last insider purchase was made public on 9 May 2024, 892 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Daniel N. Swisher Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations42 total
2,200 shares@ US$14.084.1% of flowCommon StockSEC:0001193125-25-240495:0
2,200 shares@ US$14.084.2% of flowCommon StockSEC:0001193125-25-201534:0
2,200 shares@ US$14.084.4% of flowCommon StockSEC:0001193125-25-179182:0
2,200 shares@ US$14.084.6% of flowCommon StockSEC:0000950170-25-095607:0
2,200 shares@ US$14.084.9% of flowCommon StockSEC:0000950170-25-085757:0
60,000 shares0Common StockSEC:0000950170-25-081859:0
1,800 shares@ US$12.133.8% of flowCommon StockSEC:0000950170-25-071661:0
2,200 shares@ US$12.134.5% of flowCommon StockSEC:0000950170-25-053815:0
2,200 shares@ US$12.134.7% of flowCommon StockSEC:0000950170-25-038041:0
2,200 shares@ US$12.134.9% of flowCommon StockSEC:0000950170-25-019214:0
2,200 shares@ US$12.135.0% of flowCommon StockSEC:0000950170-25-005536:0
2,200 shares@ US$12.134.8% of flowCommon StockSEC:0000950170-24-135868:0
2,200 shares@ US$12.134.8% of flowCommon StockSEC:0000950170-24-126625:0
150 shares@ US$5.860.2% of flowCommon StockSEC:0000950170-24-091076:0
2,200 shares@ US$5.862.3% of flowCommon StockSEC:0000950170-24-081593:0
40,000 shares@ US$5.0036.1% of flowCommon StockSEC:0001209191-24-005826:0
2,200 shares@ US$5.862.3% of flowCommon StockSEC:0000950170-24-069607:0
2,500 shares@ US$1.87550.9% of flowCommon StockSEC:0001209191-24-005600:0
Canonical exit: 7 Aug 2024 (T+90)
2,200 shares@ US$5.862.3% of flowCommon StockSEC:0000950170-24-052874:0
2,200 shares@ US$5.862.3% of flowCommon StockSEC:0000950170-24-041435:0
2,200 shares@ US$5.862.3% of flowCommon StockSEC:0000950170-24-026758:0
2,200 shares@ US$5.862.3% of flowCommon StockSEC:0000950170-24-010685:0
2,200 shares@ US$5.862.2% of flowCommon StockSEC:0000950170-24-002211:0
2,200 shares@ US$5.862.3% of flowCommon StockSEC:0000950170-23-068374:0
2,200 shares@ US$5.862.3% of flowCommon StockSEC:0000950170-23-058927:0
25 of 42 declarations
